Literature DB >> 23877030

DNA electroporation in rabbits as a method for generation of high-titer neutralizing antisera: examples of the botulinum toxins types A, B, and E.

Aurore Burgain1, Alice Rochard1, Capucine Trollet1, Christelle Mazuet2, Michel R Popoff2, Virginie Escriou1, Daniel Scherman1, Pascal Bigey1.   

Abstract

Raising high titer antibodies in animals is usually performed by protein immunization, which requires the long and sometimes difficult step of production of the recombinant protein. DNA immunization is an alternative to recombinant proteins, only requiring the building of an eukaryotic expression plasmid. Thanks to efficient DNA delivery techniques such as in vivo electroporation, DNA vaccination has proven useful the last few years. In this work, we have shown that it is possible to raise very high antibody titers in rabbit by DNA electroporation of an antigen encoding plasmid in the skeletal muscle with the right set of electrodes and rabbit strain. In a model of botulinum toxins types A and E, the neutralizing titers obtained after three treatments were high enough to fit the European Pharmacopeia, while it did not for type B toxin. Furthermore, the raised antibodies have high avidity and are suitable for in vitro and in vivo immunodetection of proteins.

Entities:  

Keywords:  DNA immunization; antiserum; botulinum neurotoxin; electroporation; neutralizing antibodies

Mesh:

Substances:

Year:  2013        PMID: 23877030      PMCID: PMC3906399          DOI: 10.4161/hv.25192

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  41 in total

1.  DNA vaccination protects against botulinum neurotoxin type F.

Authors:  Alice M Bennett; Stuart D Perkins; Jane L Holley
Journal:  Vaccine       Date:  2003-07-04       Impact factor: 3.641

2.  Enhancement of DNA vaccine potency in rhesus macaques by electroporation.

Authors:  Gillis Otten; Mary Schaefer; Barbara Doe; Hong Liu; Indresh Srivastava; Jan zur Megede; Derek O'Hagan; John Donnelly; Georg Widera; Dietmar Rabussay; Mark G Lewis; Susan Barnett; Jeffrey B Ulmer
Journal:  Vaccine       Date:  2004-06-23       Impact factor: 3.641

Review 3.  Passive antibody therapy for infectious diseases.

Authors:  Arturo Casadevall; Ekaterina Dadachova; Liise-anne Pirofski
Journal:  Nat Rev Microbiol       Date:  2004-09       Impact factor: 60.633

4.  In vivo electroporation improves immune responses to DNA vaccination in sheep.

Authors:  J-P Y Scheerlinck; J Karlis; T E Tjelle; P J A Presidente; I Mathiesen; S E Newton
Journal:  Vaccine       Date:  2004-04-16       Impact factor: 3.641

5.  Genetic immunization is a simple method for eliciting an immune response.

Authors:  D C Tang; M DeVit; S A Johnston
Journal:  Nature       Date:  1992-03-12       Impact factor: 49.962

Review 6.  Botulinum and tetanus neurotoxins: structure, function and therapeutic utility.

Authors:  Kathryn Turton; John A Chaddock; K Ravi Acharya
Journal:  Trends Biochem Sci       Date:  2002-11       Impact factor: 13.807

Review 7.  Botulinum toxin as a biological weapon: medical and public health management.

Authors:  S S Arnon; R Schechter; T V Inglesby; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; J Hauer; M Layton; S Lillibridge; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; D L Swerdlow; K Tonat
Journal:  JAMA       Date:  2001-02-28       Impact factor: 56.272

8.  Easy expression of the C-terminal heavy chain domain of botulinum neurotoxin serotype A as a vaccine candidate using a bi-cistronic baculovirus system.

Authors:  Oliver B Villaflores; Chein-Ming Hsei; Chao-Yi Teng; Ying-Ju Chen; Jiunn-Jye Wey; Pei-Yi Tsui; Rong-Hwa Shyu; Kuo-Lun Tung; Jui-Ming Yeh; Der-Jiang Chiao; Tzong-Yuan Wu
Journal:  J Virol Methods       Date:  2013-01-11       Impact factor: 2.014

9.  Type C botulism due to toxic feed affecting 52,000 farmed foxes and minks in Finland.

Authors:  Miia Lindström; Mari Nevas; Joanna Kurki; Raija Sauna-aho; Annikki Latvala-Kiesilä; Ilpo Pölönen; Hannu Korkeala
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

10.  Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies.

Authors:  Mahmood Tavallaie; Alexandre Chenal; Daniel Gillet; Yannik Pereira; Maria Manich; Maryse Gibert; Stephanie Raffestin; Michel R Popoff; Jean Christophe Marvaud
Journal:  FEBS Lett       Date:  2004-08-13       Impact factor: 4.124

View more
  2 in total

1.  A multipathogen DNA vaccine elicits protective immune responses against two class A bioterrorism agents, anthrax and botulism.

Authors:  Na Young Kim; Won Rak Son; Min Hoon Lee; Hong Seok Choi; Jun Young Choi; Young Jo Song; Chi Ho Yu; Dong Hyun Song; Gyeung Haeng Hur; Seong Tae Jeong; Sung Youl Hong; Young Kee Shin; Sungho Shin
Journal:  Appl Microbiol Biotechnol       Date:  2022-02-10       Impact factor: 4.813

Review 2.  Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches.

Authors:  Christine Rasetti-Escargueil; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2019-09-12       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.